Your Article Summary
Migraine treatment "tweak" could reduce office visits
The Journal of Family Practice, 07/02/09
Wells J et al. - Add dexamethasone to the standard treatment of moderate to severe migraine headache; a single dose (8-24 mg) may prevent short-term recurrence, resulting in less need for medication and fewer repeat visits to the office or emergency department. Based on this meta-analysis, it is unclear whether IV administration is required for the desired benefit.
Related Articles
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 96%
CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09
Relevance Score: 94%
Aura migraines : Aura migraines double stroke risk
Internet Source, 11/02/09
Relevance Score: 94%
Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09
Relevance Score: 94%
Normal Cortical Energy Metabolism in Migrainous Stroke. A 31P-MR Spectroscopy Study
Stroke, 10/20/09
Relevance Score: 94%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Divalproex Sodium-Induced Eosinophilic Pleural Effusion
American Journal of Therapeutics, 12/04/09
Lithium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/04/09
Acute Generalized Exanthematous Pustulosis: A Rare Clinical Entity With Use of Piperacillin/Tazobactam
American Journal of Therapeutics, 12/04/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Foam sclerotherapy: cardiac and cerebral monitoring
Phlebology, 12/04/09
Lapatinib Plus Capecitabine Resolved Human Epidermal Growth Factor Receptor 2-Positive Brain Metastases
American Journal of Therapeutics, 12/04/09
Lipid profile in normal weight migraineurs – evidence for cardiovascular risk
European Journal of Neurology, 12/04/09

See Latest Articles